EUS-guided fine-needle tissue acquisition by using a 19-gauge needle in a selected patient population: a prospective study

Background The ability to obtain tissue samples for histological examination during EUS has theoretical advantages over cytology alone. Objective To prospectively evaluate the feasibility and yield of EUS-guided fine-needle tissue acquisition (EUS-FNTA) with a large-gauge needle in patients in whom...

Full description

Saved in:
Bibliographic Details
Published inGastrointestinal endoscopy Vol. 74; no. 3; pp. 504 - 510
Main Authors Larghi, Alberto, MD, PhD, Verna, Elizabeth C., MD, Ricci, Riccardo, MD, Seerden, Tom C., MD, PhD, Galasso, Domenico, MD, Carnuccio, Antonella, MD, PhD, Uchida, Naohito, MD, Rindi, Guido, MD, PhD, Costamagna, Guido, MD, FACG
Format Journal Article
LanguageEnglish
Published Maryland heights, MO Mosby, Inc 01.09.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The ability to obtain tissue samples for histological examination during EUS has theoretical advantages over cytology alone. Objective To prospectively evaluate the feasibility and yield of EUS-guided fine-needle tissue acquisition (EUS-FNTA) with a large-gauge needle in patients in whom we expected histology to be more useful than cytology to reach a definitive diagnosis. Design Prospective cohort study. Setting Tertiary care academic medical center. Patients Consecutive patients with subepithelial lesions, esophagogastric wall thickening, mediastinal and abdominal masses/lymphadenopathy of unknown origin, or pancreatic lesions after nondiagnostic FNA. Interventions EUS-FNTA with a 19-gauge needle. Main Outcome Measurements Feasibility and yield of EUS-FNTA. Results A total of 120 patients with a mean age of 61 ± 14.6 years and mean lesion size of 38 ± 25 mm (range 8-140 mm) were enrolled. FNTA was successfully performed in all but 1 patient (98.9%), and adequate samples for histological examination were obtained in 116 of the 119 patients (97.5%) in whom EUS-FNTA was technically successful. A mean of 2.8 ± 0.8 passes per patient were performed. At the time of current follow-up, a definitive diagnosis was available in 117 of the 120 patients (97.5%), with only 8 false-negative results. The sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy of EUS-FNTA in the 117 patients with a definitive diagnosis were 91.8%, 100%, 100%, 71.4%, and 93.2%, respectively. Limitations Single-center study with limited power. Conclusions EUS-FNTA by using a large-gauge needle has a high yield and promising diagnostic accuracy and could be used when histology may be more useful than cytology to reach a definitive diagnosis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0016-5107
1097-6779
DOI:10.1016/j.gie.2011.05.014